Antifibrotic effect of AT-1 blocker and statin in rats with hepatic fibrosis (Q40736144)

23 September 2017

Antifibrotic effect of AT-1 blocker and statin in rats with hepatic fibrosis (English)

1 reference

23 September 2017

Nahla E El-Ashmawy

1

1 reference

23 September 2017

Hoda A El-Bahrawy

series ordinal

2

1 reference

23 September 2017

Maha M Shamloula

series ordinal

3

1 reference

23 September 2017

Amera O Ibrahim

series ordinal

4

1 reference

23 September 2017

14 July 2015

1 reference

Clinical and Experimental Pharmacology and Physiology

23 September 2017

1 reference

The role of the renin-angiotensin system in liver fibrosis

23 September 2017

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Evolving therapies for liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Hepatic fibrosis and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Immunohistochemical studies of stellate cells in experimental cholestasis in newborn and adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Beneficial effects of yam on carbon tetrachloride-induced hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Circulating markers of liver fibrosis progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Determination of hydroxyproline in plasma and tissue using electrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Effects of Ginkgo biloba extract on cell proliferation, cytokines and extracellular matrix of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Host genetic factors influence disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

Cellular antioxidant effects of atorvastatin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12446

21 January 2018

Identifiers

DOI

10.1111/1440-1681.12446

0 references

1 reference